Global Intravenous IV Solutions Market 2023-2027

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	153 Pages	TechNavio	April, 2023	INF17954987

Best Price Guarantee
Price	from $2,500
Length	153 Pages
Publisher	TechNavio
Published Date	April, 2023
SKU	INF17954987

Global Intravenous IV Solutions Market 2023-2027

Technavio has been monitoring the intravenous IV solutions market and is forecast to grow by USD 4011.34 mn during 2022-2027, accelerating at a CAGR of 7.11% during the forecast period. Our report on the intravenous iv solutions market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of chronic diseases, the growing geriatric population, and the increasing demand for parenteral nutrition.

Technavio's intravenous IV solutions market is segmented as below:

By Type

Partial parenteral nutrition
Total parenteral nutrition

By Distribution Channel

Hospital pharmacy
Retail pharmacy
Online pharmacy

By Geographical Landscape

Asia
North America
Europe
Rest of World (ROW)

This study identifies the technological advancements in iv solutions as one of the prime reasons driving the intravenous iv solutions market growth during the next few years. Also, increasing demand for home healthcare and growing investments in the healthcare sector will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the intravenous iv solutions market covers the following areas:

Intravenous IV solutions market sizing
Intravenous IV solutions market forecast
Intravenous IV solutions market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading intravenous iv solutions market vendors that include Amanta Healthcare Ltd., Axa Parenterals Ltd., Baxter International Inc., Fresenius SE and Co. KGaA, Grifols SA, ICU Medical Inc., JW Pharmaceutical Corp., Lxir Medilabs Pvt. Ltd., MITS Healthcare Pvt. Ltd., Pfizer Inc., Salius Pharma Pvt. Ltd., Schwitz Biotech, Sichuan Kelun Pharmaceutical Co. Ltd., Soxa Formulations and Research Pvt. Ltd., Terumo Group, Vifor Pharma Management Ltd., Vikrant Life Sciences Pvt. Ltd., Vitapure Corp., B. Braun Melsungen AG, and Otsuka Holdings Co. Ltd.. Also, the intravenous iv solutions market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Exhibit 01: Executive Summary - Chart on Market Overview; Exhibit 02: Executive Summary - Data Table on Market Overview; Exhibit 03: Executive Summary - Chart on Global Market Characteristics; Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape; Exhibit 05: Executive Summary - Chart on Market Segmentation by Type; Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel; Exhibit 07: Executive Summary - Chart on Incremental Growth; Exhibit 08: Executive Summary - Data Table on Incremental Growth; Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Exhibit 10: Parent market; Exhibit 11: Market Characteristics
3 Market Sizing: 3.1 Market definition; Exhibit 12: Offerings of vendors included in the market definition; 3.2 Market segment analysis; Exhibit 13: Market segments; 3.3 Market size 2022; 3.4 Market outlook: Forecast for 2022-2027; Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million); Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million); Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%); Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size: 4.1 Global intravenous (IV) solutions market 2017 - 2021; Exhibit 18: Historic Market Size - Data Table on global intravenous (iv) solutions market 2017 - 2021 ($ million); 4.2 Type Segment Analysis 2017 - 2021; Exhibit 19: Historic Market Size - Type Segment 2017 - 2021 ($ million); 4.3 Distribution Channel Segment Analysis 2017 - 2021; Exhibit 20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million); 4.4 Geography Segment Analysis 2017 - 2021; Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million); 4.5 Country Segment Analysis 2017 - 2021; Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Exhibit 23: Five forces analysis - Comparison between 2022 and 2027; 5.2 Bargaining power of buyers; Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027; 5.3 Bargaining power of suppliers; Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027; 5.4 Threat of new entrants; Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027; 5.5 Threat of substitutes; Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027; 5.6 Threat of rivalry; Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027; 5.7 Market condition; Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Type: 6.1 Market segments; Exhibit 30: Chart on Type - Market share 2022-2027 (%); Exhibit 31: Data Table on Type - Market share 2022-2027 (%); 6.2 Comparison by Type; Exhibit 32: Chart on Comparison by Type; Exhibit 33: Data Table on Comparison by Type; 6.3 Partial parenteral nutrition - Market size and forecast 2022-2027; Exhibit 34: Chart on Partial parenteral nutrition - Market size and forecast 2022-2027 ($ million); Exhibit 35: Data Table on Partial parenteral nutrition - Market size and forecast 2022-2027 ($ million); Exhibit 36: Chart on Partial parenteral nutrition - Year-over-year growth 2022-2027 (%); Exhibit 37: Data Table on Partial parenteral nutrition - Year-over-year growth 2022-2027 (%); 6.4 Total parenteral nutrition - Market size and forecast 2022-2027; Exhibit 38: Chart on Total parenteral nutrition - Market size and forecast 2022-2027 ($ million); Exhibit 39: Data Table on Total parenteral nutrition - Market size and forecast 2022-2027 ($ million); Exhibit 40: Chart on Total parenteral nutrition - Year-over-year growth 2022-2027 (%); Exhibit 41: Data Table on Total parenteral nutrition - Year-over-year growth 2022-2027 (%); 6.5 Market opportunity by Type; Exhibit 42: Market opportunity by Type ($ million); Exhibit 43: Data Table on Market opportunity by Type ($ million)
7 Market Segmentation by Distribution Channel: 7.1 Market segments; Exhibit 44: Chart on Distribution Channel - Market share 2022-2027 (%); Exhibit 45: Data Table on Distribution Channel - Market share 2022-2027 (%); 7.2 Comparison by Distribution Channel; Exhibit 46: Chart on Comparison by Distribution Channel; Exhibit 47: Data Table on Comparison by Distribution Channel; 7.3 Hospital pharmacy - Market size and forecast 2022-2027; Exhibit 48: Chart on Hospital pharmacy - Market size and forecast 2022-2027 ($ million); Exhibit 49: Data Table on Hospital pharmacy - Market size and forecast 2022-2027 ($ million); Exhibit 50: Chart on Hospital pharmacy - Year-over-year growth 2022-2027 (%); Exhibit 51: Data Table on Hospital pharmacy - Year-over-year growth 2022-2027 (%); 7.4 Retail pharmacy - Market size and forecast 2022-2027; Exhibit 52: Chart on Retail pharmacy - Market size and forecast 2022-2027 ($ million); Exhibit 53: Data Table on Retail pharmacy - Market size and forecast 2022-2027 ($ million); Exhibit 54: Chart on Retail pharmacy - Year-over-year growth 2022-2027 (%); Exhibit 55: Data Table on Retail pharmacy - Year-over-year growth 2022-2027 (%); 7.5 Online pharmacy - Market size and forecast 2022-2027; Exhibit 56: Chart on Online pharmacy - Market size and forecast 2022-2027 ($ million); Exhibit 57: Data Table on Online pharmacy - Market size and forecast 2022-2027 ($ million); Exhibit 58: Chart on Online pharmacy - Year-over-year growth 2022-2027 (%); Exhibit 59: Data Table on Online pharmacy - Year-over-year growth 2022-2027 (%); 7.6 Market opportunity by Distribution Channel; Exhibit 60: Market opportunity by Distribution Channel ($ million); Exhibit 61: Data Table on Market opportunity by Distribution Channel ($ million)
8 Customer Landscape: 8.1 Customer landscape overview; Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Exhibit 63: Chart on Market share By Geographical Landscape 2022-2027 (%); Exhibit 64: Data Table on Market share By Geographical Landscape 2022-2027 (%); 9.2 Geographic comparison; Exhibit 65: Chart on Geographic comparison; Exhibit 66: Data Table on Geographic comparison; 9.3 Asia - Market size and forecast 2022-2027; Exhibit 67: Chart on Asia - Market size and forecast 2022-2027 ($ million); Exhibit 68: Data Table on Asia - Market size and forecast 2022-2027 ($ million); Exhibit 69: Chart on Asia - Year-over-year growth 2022-2027 (%); Exhibit 70: Data Table on Asia - Year-over-year growth 2022-2027 (%); 9.4 North America - Market size and forecast 2022-2027; Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million); Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million); Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%); Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%); 9.5 Europe - Market size and forecast 2022-2027; Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million); Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million); Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%); Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%); 9.6 Rest of World (ROW) - Market size and forecast 2022-2027; Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million); Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million); Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%); Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%); 9.7 US - Market size and forecast 2022-2027; Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million); Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million); Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%); Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%); 9.8 Germany - Market size and forecast 2022-2027; Exhibit 87: Chart on Germany - Market size and forecast 2022-2027 ($ million); Exhibit 88: Data Table on Germany - Market size and forecast 2022-2027 ($ million); Exhibit 89: Chart on Germany - Year-over-year growth 2022-2027 (%); Exhibit 90: Data Table on Germany - Year-over-year growth 2022-2027 (%); 9.9 China - Market size and forecast 2022-2027; Exhibit 91: Chart on China - Market size and forecast 2022-2027 ($ million); Exhibit 92: Data Table on China - Market size and forecast 2022-2027 ($ million); Exhibit 93: Chart on China - Year-over-year growth 2022-2027 (%); Exhibit 94: Data Table on China - Year-over-year growth 2022-2027 (%); 9.10 UK - Market size and forecast 2022-2027; Exhibit 95: Chart on UK - Market size and forecast 2022-2027 ($ million); Exhibit 96: Data Table on UK - Market size and forecast 2022-2027 ($ million); Exhibit 97: Chart on UK - Year-over-year growth 2022-2027 (%); Exhibit 98: Data Table on UK - Year-over-year growth 2022-2027 (%); 9.11 Canada - Market size and forecast 2022-2027; Exhibit 99: Chart on Canada - Market size and forecast 2022-2027 ($ million); Exhibit 100: Data Table on Canada - Market size and forecast 2022-2027 ($ million); Exhibit 101: Chart on Canada - Year-over-year growth 2022-2027 (%); Exhibit 102: Data Table on Canada - Year-over-year growth 2022-2027 (%); 9.12 Market opportunity By Geographical Landscape; Exhibit 103: Market opportunity By Geographical Landscape ($ million); Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Exhibit 105: Impact of drivers and challenges in 2022 and 2027; 10.4 Market trends
11 Vendor Landscape: 11.1 Overview; 11.2 Vendor landscape; Exhibit 106: Overview on Criticality of inputs and Factors of differentiation; 11.3 Landscape disruption; Exhibit 107: Overview on factors of disruption; 11.4 Industry risks; Exhibit 108: Impact of key risks on business
12 Vendor Analysis: 12.1 Vendors covered; Exhibit 109: Vendors covered; 12.2 Market positioning of vendors; Exhibit 110: Matrix on vendor position and classification; 12.3 Amanta Healthcare Ltd.; Exhibit 111: Amanta Healthcare Ltd. - Overview; Exhibit 112: Amanta Healthcare Ltd. - Product / Service; Exhibit 113: Amanta Healthcare Ltd. - Key offerings; 12.4 Axa Parenterals Ltd.; Exhibit 114: Axa Parenterals Ltd. - Overview; Exhibit 115: Axa Parenterals Ltd. - Product / Service; Exhibit 116: Axa Parenterals Ltd. - Key offerings; 12.5 B. Braun Melsungen AG; Exhibit 117: B. Braun Melsungen AG - Overview; Exhibit 118: B. Braun Melsungen AG - Business segments; Exhibit 119: B. Braun Melsungen AG - Key news; Exhibit 120: B. Braun Melsungen AG - Key offerings; Exhibit 121: B. Braun Melsungen AG - Segment focus; 12.6 Baxter International Inc.; Exhibit 122: Baxter International Inc. - Overview; Exhibit 123: Baxter International Inc. - Business segments; Exhibit 124: Baxter International Inc. - Key news; Exhibit 125: Baxter International Inc. - Key offerings; Exhibit 126: Baxter International Inc. - Segment focus; 12.7 Fresenius SE and Co. KGaA; Exhibit 127: Fresenius SE and Co. KGaA - Overview; Exhibit 128: Fresenius SE and Co. KGaA - Business segments; Exhibit 129: Fresenius SE and Co. KGaA - Key news; Exhibit 130: Fresenius SE and Co. KGaA - Key offerings; Exhibit 131: Fresenius SE and Co. KGaA - Segment focus; 12.8 Grifols SA; Exhibit 132: Grifols SA - Overview; Exhibit 133: Grifols SA - Business segments; Exhibit 134: Grifols SA - Key offerings; Exhibit 135: Grifols SA - Segment focus; 12.9 ICU Medical Inc.; Exhibit 136: ICU Medical Inc. - Overview; Exhibit 137: ICU Medical Inc. - Product / Service; Exhibit 138: ICU Medical Inc. - Key offerings; 12.10 JW Pharmaceutical Corp.; Exhibit 139: JW Pharmaceutical Corp. - Overview; Exhibit 140: JW Pharmaceutical Corp. - Product / Service; Exhibit 141: JW Pharmaceutical Corp. - Key offerings; 12.11 Otsuka Holdings Co. Ltd.; Exhibit 142: Otsuka Holdings Co. Ltd. - Overview; Exhibit 143: Otsuka Holdings Co. Ltd. - Business segments; Exhibit 144: Otsuka Holdings Co. Ltd. - Key offerings; Exhibit 145: Otsuka Holdings Co. Ltd. - Segment focus; 12.12 Pfizer Inc.; Exhibit 146: Pfizer Inc. - Overview; Exhibit 147: Pfizer Inc. - Product / Service; Exhibit 148: Pfizer Inc. - Key news; Exhibit 149: Pfizer Inc. - Key offerings; 12.13 Salius Pharma Pvt. Ltd.; Exhibit 150: Salius Pharma Pvt. Ltd. - Overview; Exhibit 151: Salius Pharma Pvt. Ltd. - Product / Service; Exhibit 152: Salius Pharma Pvt. Ltd. - Key offerings; 12.14 Sichuan Kelun Pharmaceutical Co. Ltd.; Exhibit 153: Sichuan Kelun Pharmaceutical Co. Ltd. - Overview; Exhibit 154: Sichuan Kelun Pharmaceutical Co. Ltd. - Product / Service; Exhibit 155: Sichuan Kelun Pharmaceutical Co. Ltd. - Key offerings; 12.15 Soxa Formulations and Research Pvt. Ltd.; Exhibit 156: Soxa Formulations and Research Pvt. Ltd. - Overview; Exhibit 157: Soxa Formulations and Research Pvt. Ltd. - Product / Service; Exhibit 158: Soxa Formulations and Research Pvt. Ltd. - Key offerings; 12.16 Terumo Group; Exhibit 159: Terumo Group - Overview; Exhibit 160: Terumo Group - Business segments; Exhibit 161: Terumo Group - Key news; Exhibit 162: Terumo Group - Key offerings; Exhibit 163: Terumo Group - Segment focus; 12.17 Vifor Pharma Management Ltd.; Exhibit 164: Vifor Pharma Management Ltd. - Overview; Exhibit 165: Vifor Pharma Management Ltd. - Product / Service; Exhibit 166: Vifor Pharma Management Ltd. - Key news; Exhibit 167: Vifor Pharma Management Ltd. - Key offerings
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Exhibit 168: Inclusions checklist; Exhibit 169: Exclusions checklist; 13.3 Currency conversion rates for US$; Exhibit 170: Currency conversion rates for US$; 13.4 Research methodology; Exhibit 171: Research methodology; Exhibit 172: Validation techniques employed for market sizing; Exhibit 173: Information sources; 13.5 List of abbreviations; Exhibit 174: List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Type; Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Vendor Market Positioning; Exhibits10: Parent market; Exhibits11: Market Characteristics; Exhibits12: Offerings of vendors included in the market definition; Exhibits13: Market segments; Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million); Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million); Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%); Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%); Exhibits18: Historic Market Size - Data Table on global intravenous (iv) solutions market 2017 - 2021 ($ million); Exhibits19: Historic Market Size - Type Segment 2017 - 2021 ($ million); Exhibits20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million); Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million); Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million); Exhibits23: Five forces analysis - Comparison between 2022 and 2027; Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027; Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027; Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027; Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027; Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027; Exhibits29: Chart on Market condition - Five forces 2022 and 2027; Exhibits30: Chart on Type - Market share 2022-2027 (%); Exhibits31: Data Table on Type - Market share 2022-2027 (%); Exhibits32: Chart on Comparison by Type; Exhibits33: Data Table on Comparison by Type; Exhibits34: Chart on Partial parenteral nutrition - Market size and forecast 2022-2027 ($ million); Exhibits35: Data Table on Partial parenteral nutrition - Market size and forecast 2022-2027 ($ million); Exhibits36: Chart on Partial parenteral nutrition - Year-over-year growth 2022-2027 (%); Exhibits37: Data Table on Partial parenteral nutrition - Year-over-year growth 2022-2027 (%); Exhibits38: Chart on Total parenteral nutrition - Market size and forecast 2022-2027 ($ million); Exhibits39: Data Table on Total parenteral nutrition - Market size and forecast 2022-2027 ($ million); Exhibits40: Chart on Total parenteral nutrition - Year-over-year growth 2022-2027 (%); Exhibits41: Data Table on Total parenteral nutrition - Year-over-year growth 2022-2027 (%); Exhibits42: Market opportunity by Type ($ million); Exhibits43: Data Table on Market opportunity by Type ($ million); Exhibits44: Chart on Distribution Channel - Market share 2022-2027 (%); Exhibits45: Data Table on Distribution Channel - Market share 2022-2027 (%); Exhibits46: Chart on Comparison by Distribution Channel; Exhibits47: Data Table on Comparison by Distribution Channel; Exhibits48: Chart on Hospital pharmacy - Market size and forecast 2022-2027 ($ million); Exhibits49: Data Table on Hospital pharmacy - Market size and forecast 2022-2027 ($ million); Exhibits50: Chart on Hospital pharmacy - Year-over-year growth 2022-2027 (%); Exhibits51: Data Table on Hospital pharmacy - Year-over-year growth 2022-2027 (%); Exhibits52: Chart on Retail pharmacy - Market size and forecast 2022-2027 ($ million); Exhibits53: Data Table on Retail pharmacy - Market size and forecast 2022-2027 ($ million); Exhibits54: Chart on Retail pharmacy - Year-over-year growth 2022-2027 (%); Exhibits55: Data Table on Retail pharmacy - Year-over-year growth 2022-2027 (%); Exhibits56: Chart on Online pharmacy - Market size and forecast 2022-2027 ($ million); Exhibits57: Data Table on Online pharmacy - Market size and forecast 2022-2027 ($ million); Exhibits58: Chart on Online pharmacy - Year-over-year growth 2022-2027 (%); Exhibits59: Data Table on Online pharmacy - Year-over-year growth 2022-2027 (%); Exhibits60: Market opportunity by Distribution Channel ($ million); Exhibits61: Data Table on Market opportunity by Distribution Channel ($ million); Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits63: Chart on Market share By Geographical Landscape 2022-2027 (%); Exhibits64: Data Table on Market share By Geographical Landscape 2022-2027 (%); Exhibits65: Chart on Geographic comparison; Exhibits66: Data Table on Geographic comparison; Exhibits67: Chart on Asia - Market size and forecast 2022-2027 ($ million); Exhibits68: Data Table on Asia - Market size and forecast 2022-2027 ($ million); Exhibits69: Chart on Asia - Year-over-year growth 2022-2027 (%); Exhibits70: Data Table on Asia - Year-over-year growth 2022-2027 (%); Exhibits71: Chart on North America - Market size and forecast 2022-2027 ($ million); Exhibits72: Data Table on North America - Market size and forecast 2022-2027 ($ million); Exhibits73: Chart on North America - Year-over-year growth 2022-2027 (%); Exhibits74: Data Table on North America - Year-over-year growth 2022-2027 (%); Exhibits75: Chart on Europe - Market size and forecast 2022-2027 ($ million); Exhibits76: Data Table on Europe - Market size and forecast 2022-2027 ($ million); Exhibits77: Chart on Europe - Year-over-year growth 2022-2027 (%); Exhibits78: Data Table on Europe - Year-over-year growth 2022-2027 (%); Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million); Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million); Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%); Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%); Exhibits83: Chart on US - Market size and forecast 2022-2027 ($ million); Exhibits84: Data Table on US - Market size and forecast 2022-2027 ($ million); Exhibits85: Chart on US - Year-over-year growth 2022-2027 (%); Exhibits86: Data Table on US - Year-over-year growth 2022-2027 (%); Exhibits87: Chart on Germany - Market size and forecast 2022-2027 ($ million); Exhibits88: Data Table on Germany - Market size and forecast 2022-2027 ($ million); Exhibits89: Chart on Germany - Year-over-year growth 2022-2027 (%); Exhibits90: Data Table on Germany - Year-over-year growth 2022-2027 (%); Exhibits91: Chart on China - Market size and forecast 2022-2027 ($ million); Exhibits92: Data Table on China - Market size and forecast 2022-2027 ($ million); Exhibits93: Chart on China - Year-over-year growth 2022-2027 (%); Exhibits94: Data Table on China - Year-over-year growth 2022-2027 (%); Exhibits95: Chart on UK - Market size and forecast 2022-2027 ($ million); Exhibits96: Data Table on UK - Market size and forecast 2022-2027 ($ million); Exhibits97: Chart on UK - Year-over-year growth 2022-2027 (%); Exhibits98: Data Table on UK - Year-over-year growth 2022-2027 (%); Exhibits99: Chart on Canada - Market size and forecast 2022-2027 ($ million); Exhibits100: Data Table on Canada - Market size and forecast 2022-2027 ($ million); Exhibits101: Chart on Canada - Year-over-year growth 2022-2027 (%); Exhibits102: Data Table on Canada - Year-over-year growth 2022-2027 (%); Exhibits103: Market opportunity By Geographical Landscape ($ million); Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ million); Exhibits105: Impact of drivers and challenges in 2022 and 2027; Exhibits106: Overview on Criticality of inputs and Factors of differentiation; Exhibits107: Overview on factors of disruption; Exhibits108: Impact of key risks on business; Exhibits109: Vendors covered; Exhibits110: Matrix on vendor position and classification; Exhibits111: Amanta Healthcare Ltd. - Overview; Exhibits112: Amanta Healthcare Ltd. - Product / Service; Exhibits113: Amanta Healthcare Ltd. - Key offerings; Exhibits114: Axa Parenterals Ltd. - Overview; Exhibits115: Axa Parenterals Ltd. - Product / Service; Exhibits116: Axa Parenterals Ltd. - Key offerings; Exhibits117: B. Braun Melsungen AG - Overview; Exhibits118: B. Braun Melsungen AG - Business segments; Exhibits119: B. Braun Melsungen AG - Key news; Exhibits120: B. Braun Melsungen AG - Key offerings; Exhibits121: B. Braun Melsungen AG - Segment focus; Exhibits122: Baxter International Inc. - Overview; Exhibits123: Baxter International Inc. - Business segments; Exhibits124: Baxter International Inc. - Key news; Exhibits125: Baxter International Inc. - Key offerings; Exhibits126: Baxter International Inc. - Segment focus; Exhibits127: Fresenius SE and Co. KGaA - Overview; Exhibits128: Fresenius SE and Co. KGaA - Business segments; Exhibits129: Fresenius SE and Co. KGaA - Key news; Exhibits130: Fresenius SE and Co. KGaA - Key offerings; Exhibits131: Fresenius SE and Co. KGaA - Segment focus; Exhibits132: Grifols SA - Overview; Exhibits133: Grifols SA - Business segments; Exhibits134: Grifols SA - Key offerings; Exhibits135: Grifols SA - Segment focus; Exhibits136: ICU Medical Inc. - Overview; Exhibits137: ICU Medical Inc. - Product / Service; Exhibits138: ICU Medical Inc. - Key offerings; Exhibits139: JW Pharmaceutical Corp. - Overview; Exhibits140: JW Pharmaceutical Corp. - Product / Service; Exhibits141: JW Pharmaceutical Corp. - Key offerings; Exhibits142: Otsuka Holdings Co. Ltd. - Overview; Exhibits143: Otsuka Holdings Co. Ltd. - Business segments; Exhibits144: Otsuka Holdings Co. Ltd. - Key offerings; Exhibits145: Otsuka Holdings Co. Ltd. - Segment focus; Exhibits146: Pfizer Inc. - Overview; Exhibits147: Pfizer Inc. - Product / Service; Exhibits148: Pfizer Inc. - Key news; Exhibits149: Pfizer Inc. - Key offerings; Exhibits150: Salius Pharma Pvt. Ltd. - Overview; Exhibits151: Salius Pharma Pvt. Ltd. - Product / Service; Exhibits152: Salius Pharma Pvt. Ltd. - Key offerings; Exhibits153: Sichuan Kelun Pharmaceutical Co. Ltd. - Overview; Exhibits154: Sichuan Kelun Pharmaceutical Co. Ltd. - Product / Service; Exhibits155: Sichuan Kelun Pharmaceutical Co. Ltd. - Key offerings; Exhibits156: Soxa Formulations and Research Pvt. Ltd. - Overview; Exhibits157: Soxa Formulations and Research Pvt. Ltd. - Product / Service; Exhibits158: Soxa Formulations and Research Pvt. Ltd. - Key offerings; Exhibits159: Terumo Group - Overview; Exhibits160: Terumo Group - Business segments; Exhibits161: Terumo Group - Key news; Exhibits162: Terumo Group - Key offerings; Exhibits163: Terumo Group - Segment focus; Exhibits164: Vifor Pharma Management Ltd. - Overview; Exhibits165: Vifor Pharma Management Ltd. - Product / Service; Exhibits166: Vifor Pharma Management Ltd. - Key news; Exhibits167: Vifor Pharma Management Ltd. - Key offerings; Exhibits168: Inclusions checklist; Exhibits169: Exclusions checklist; Exhibits170: Currency conversion rates for US$; Exhibits171: Research methodology; Exhibits172: Validation techniques employed for market sizing; Exhibits173: Information sources; Exhibits174: List of abbreviations